Stock Watcher's Thread / Pix of the Week (POW) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Stock Watcher's Thread / Pix of the Week (POW)

VEEV 244.06

-9.8%

Nov 21 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Stock Watcher who wrote (14196)	8/31/1999 12:38:00 PM
From: Jeffrey L. Henken	Read Replies (1) of 52051

When WASP ran up to $2 1/2 a share last spring I was pretty skeptical. I didn't know how they could back up the claims made in their press releases. Now I've looked at the their clinical findings. All their medications are already FDA approved so getting FDA approval should be a breeze on the OTC indications. These medications have never been used in the proper combinations before, and they do need supervision, especially in the case of teenagers with acne problems, but I'm certain now that they will work in the majority of the cases. The market opportunity here is huge, just for acne alone, but they have a number of different products which all address large markets. At less than a buck WASP has a chance for some serious appreciation. That's just my opinion. Everyone should do their own due diligence. Thanks, Jeff

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next